Affordable Access

deepdyve-link
Publisher Website

Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.

Authors
  • Prasher, Parteek1
  • Sharma, Mousmee2
  • Mehta, Meenu3
  • Paudel, Keshav R4
  • Satija, Saurabh5
  • Chellappan, Dinesh K6
  • Dureja, Harish7
  • Gupta, Gaurav8
  • Tambuwala, Murtaza M9
  • Negi, Poonam10
  • Wich, Peter R11
  • Hansbro, Nicole G12
  • Hansbro, Philip M13
  • Dua, Kamal14
  • 1 Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India. , (India)
  • 2 Department of Chemistry, Uttaranchal University, Dehradun, 248007, India. , (India)
  • 3 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia. , (Australia)
  • 4 Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, 2007, Australia. , (Australia)
  • 5 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, 144411, Punjab, India. , (Australia)
  • 6 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia. , (Malaysia)
  • 7 Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, 124001, India. , (India)
  • 8 School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India. , (India)
  • 9 School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine, County Londonderry, BT52 1SA, Northern Ireland, United Kingdom. , (United Kingdom)
  • 10 School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh, 173229, India. , (India)
  • 11 Australian Centre for NanoMedicine, University of New South Wales, Sydney, NSW, 2052, Australia; School of Chemical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia. , (Australia)
  • 12 Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, 2007, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia. , (Australia)
  • 13 Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, 2007, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia. , (Australia)
  • 14 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW, 2007, Australia; Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia; School of Pharmaceutical Sciences, Shoolini University, Bajhol, Sultanpur, Solan, Himachal Pradesh, 173229, India; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia; Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI) & School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, 2308, Australia. Electronic address: [email protected] , (Australia)
Type
Published Article
Journal
Chemico-biological interactions
Publication Date
Jul 01, 2020
Volume
325
Pages
109125–109125
Identifiers
DOI: 10.1016/j.cbi.2020.109125
PMID: 32376238
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The apparent predicament of the representative chemotherapy for managing respiratory distress calls for an obligatory deliberation for identifying the pharmaceuticals that effectively counter the contemporary intricacies associated with target disease. Multiple, complex regulatory pathways manifest chronic pulmonary disorders, which require chemotherapeutics that produce composite inhibitory effect. The cost effective natural product based molecules hold a high fervor to meet the prospects posed by current respiratory-distress therapy by sparing the tedious drug design and development archetypes, present a robust standing for the possible replacement of the fading practice of poly-pharmacology, and ensure the subversion of a potential disease relapse. This study summarizes the experimental evidences on natural products moieties and their components that illustrates therapeutic efficacy on respiratory disorders. Copyright © 2020 Elsevier B.V. All rights reserved.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 01/04/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/32376238
Report this publication

Statistics

Seen <100 times